アセタルデヒド脱水素酵素18A1のタンパク質キナーゼ活性によるc-MycのSer62でのリン酸化は腫瘍の成長を促進する.
PubMedで要約を見る
まとめ
この要約は機械生成です。アセタルデヒド脱水酵素18A1 (ALDH18A1) は,オンコタンパク質c- Mycをリン酸化し,安定させ,がんを誘発する. トンゾニウムブロミド (TB) とのこのALDH18A1- MYC相互作用を抑制することは,臨床前がんモデルにおいて治療的可能性を示しています.
科学分野
- 生物化学
- 分子生物学
- 腫瘍学
背景
- 腫瘍タンパク質c-Mycは癌において極めて重要であり,その安定性は治療戦略に影響を与えます.
- Ser62でのリン酸化は,c- Mycの分解を防止し,半減期を延長する重要なメカニズムです.
研究 の 目的
- 新しいがんの介入のためのSer62でc-Mycリン酸化を調節するキナーゼを特定する.
- c-Mycの調節と癌の発症におけるアセタルデヒド脱水素酶18A1 (ALDH18A1) の役割を解明する.
主な方法
- ALDH18A1のγ-グルタミン酸キナーゼ (γ-GK) ドメインを用いてキナーゼ活性を調べた.
- ALDH18A1とc-Mycのフィードバックループを分析した.
- ALDH18A1-c-Mycの相互作用を抑制するFDA承認の薬剤をスクリーニングした.
主要な成果
- ALDH18A1はタンパク質キナーゼとして作用し,Ser62でc- Mycをリン酸化し,その分解を抑制する.
- ALDH18A1とc- Mycの間のポジティブなフィードバックループは腫瘍の発達を促進します.
- トンゾニウムブロミド (TB) は,ALDH18A1媒介によるc- Mycリン酸化を阻害し,臨床前モデルでは腫瘍の進行を減少させる.
結論
- ALDH18A1は新しいキナーゼで c-Mycを安定させ 癌を駆動する 規制回路を作り出します
- ALDH18A1-MYC軸を 結核のような阻害剤で標的にすることは 人間の癌に対する有望な治療戦略です
関連する概念動画
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

